City

Atlanta (1)

Chicago (1)

Cincinnati (1)

Columbus (1)

Houston (1)

Jacksonville (1)

Seattle (1)

Condition

Chronic Myeloid Leukemia, Blast Crisis (2)

Acute Myelogenous Leukemia (1)

Acute Myeloid Leukemia (1)

B-cell Acute Lymphoblastic Leukemia (1)

Blastic Plasmacytoid Dendritic Cell Neoplasm (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

University of Cincinnati (1)

Xencor, Inc. (1)

Collaborator

ICON Clinical Research (1)

Novartis (1)

Intervention

clag (1)

imatinib mesylate (1)

xmab14045 (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

chronic myeloid leukemia, blast crisis

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

Completed

Acute Myelogenous Leukemia
+3 more

XmAb14045

Jacksonville, Florida
+8 more

Mar 4, 2022

Chronic Myeloid Leukemia, Blast Crisis, Acute Myeloid Leukemia Trial in Cincinnati (Imatinib Mesylate, CLAG)

Withdrawn

Chronic Myeloid Leukemia, Blast Crisis
Acute Myeloid Leukemia

Imatinib Mesylate
CLAG

Cincinnati, Ohio

University of Cincinnati

Oct 29, 2008